The pharmacokinetics of tacrolimus in peripheral blood mononuclear cells and limited sampling strategy for estimation of exposure in renal transplant recipients.

Purpose: Intracellular exposure of tacrolimus (TAC) may be a better marker of therapeutic effect than whole blood exposure. We aimed to evaluate the influence of genetic polymorphism on the pharmacokinetics of TAC in peripheral blood mononuclear cells (PBMCs) and develop limited sampling strategy (L...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Clinical Pharmacology Vol. 78; no. 8; pp. 1261 - 1273
Autores principales: Wang, Xi-Han, Shao, Kun, An, Hui-Min, Zhai, Xiao-Hui, Zhou, Pei-Jun, Chen, Bing
Formato: research tables/charts Journal Article
Publicado: Springer Nature Aug2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=157988211&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 157988211
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00316970
        NP9
      jtl: European Journal of Clinical Pharmacology
      issn: 00316970
      maglogo: N
    pubinfo:
      dt: Aug2022
      vid: 78
      iid: 8
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        157988211
        156782693
        157988211
        157988211
        10.1007/s00228-021-03215-9
        157988211
      ppf: 1261
      ppct: 12
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: The pharmacokinetics of tacrolimus in peripheral blood mononuclear cells and limited sampling strategy for estimation of exposure in renal transplant recipients.
      aug:
        au:
          Wang, Xi-Han
          Shao, Kun
          An, Hui-Min
          Zhai, Xiao-Hui
          Zhou, Pei-Jun
          Chen, Bing
        affil: Department of Pharmacy, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
      sug:
        subj:
          Tacrolimus Pharmacokinetics
          Blood Cells Drug Effects
          Polymorphism, Genetic Physiology
          Kidney Transplantation
          Transplant Recipients
          Human
          Immunosuppression
          Descriptive Statistics
      ab: Purpose: Intracellular exposure of tacrolimus (TAC) may be a better marker of therapeutic effect than whole blood exposure. We aimed to evaluate the influence of genetic polymorphism on the pharmacokinetics of TAC in peripheral blood mononuclear cells (PBMCs) and develop limited sampling strategy (LSS) models to estimate the area under the curve (AUC0–12h) in the PBMC of Chinese renal transplant patients. Methods: Ten blood samples of each of the 23 renal transplant patients were collected 0–12h after 14 (10–18) days of TAC administration. PBMCs were separated and quantified. The TAC level in PBMCs was determined, and pharmacokinetic parameters were estimated by noncompartmental study. The AUC0–12h of TAC in whole blood was estimated by Bayesian approach based on a population pharmacokinetic model established in 65 renal transplant patients. The influence of CYP3A5 and ABCB1 genotypes on exposure was estimated. By applying multiple stepwise linear regression analysis, LSS equations for TAC AUC0–12h in the PMBC of renal transplant patients were established, and the bias and precision of various equations were identified and compared. Results: We found a modest correlation between TAC exposure in whole blood and PBMC (r2 = 0.5260). Patients with the CYP3A5 6986GG genotype had a higher AUC0–12h in PBMCs than those with the 6986 AA or GA genotype (P = 0.026). Conversely, patients with the ABCB1 3435TT genotype had a higher AUC0–12h in PBMC than those with the 3435 CC and CT genotypes (P = 0.046). LSS models with 1–4 blood time points were established (r2 = 0.570–0.989). The best model for predicting TAC AUC0–12h was C2–C4–C6–C10 (r2 = 0.989). The model with C0.5–C6 (r2 = 0.849) can be used for outpatients who need monitoring to be performed in a short period. Conclusions: The CYP3A5 and ABCB1 genotypes impact TAC exposure in PBMCs, which may further alter the effects of TAC. The LSS model consisting of 2–4 time points is an effective approach for estimating full TAC AUC0–12h in Chinese renal transplant patients. This approach may provide convenience and the possibility for clinical monitoring of TAC intracellular exposure.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N